Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
16.1%
% of XLV's 62 holdings also in HRTS
25.6%
% of HRTS's 39 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus HRTS)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.0% | 7.2% | 7.2% |
|
AMGEN INC | 2.8% | 3.8% | 2.8% |
|
BOSTON SCIENTIFIC CORP | 2.6% | 2.6% | 2.6% |
|
VERTEX PHARMACEUTICALS INC | 2.3% | 5.8% | 2.3% |
 |
MEDTRONIC PLC | 2.0% | 2.4% | 2.0% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to HRTS
|
UNITEDHEALTH GROUP INC | 9.3% |
|
JOHNSON & JOHNSON | 6.8% |
|
ABBVIE INC | 5.9% |
|
MERCK & CO. INC. | 5.0% |
|
ELI LILLY & CO | 4.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.9% |
|
ABBOTT LABORATORIES | 3.8% |
|
INTUITIVE SURGICAL INC | 3.7% |
|
DANAHER CORP | 2.9% |
|
PFIZER INC | 2.8% |
XLV Underweight Relative to HRTS
|
ALNYLAM PHARMACEUTICALS INC | -5.0% |
|
BRIDGEBIO PHARMA, INC. | -4.2% |
 |
NOVO NORDISK A/S-B | -3.9% |
|
CRINETICS PHARMACEUTICALS INC | -3.8% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.7% |
 |
ASTRAZENECA PLC | -3.6% |
|
ASCENDIS PHARMA A/S | -3.5% |
|
VERTEX PHARMACEUTICALS INC | -3.4% |
|
CYTOKINETICS INC | -3.3% |
|
MASIMO CORPORATION | -2.8% |